Clinical Trial Update: A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating MetMAb in combination with Tarceva (erlotinib) for advanced non-small cell lung cancer has completed, with results posted on 2011-10-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• MetMAb (onartuzumab)
• Tarceva (erlotinib)

Snippet

Sponsor: Genentech, Inc. | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-10-18